CASE STUDY: How SLS is used to 3D print personalized Medicine – FabRx Customer Story

FabRx is a spin-out company from the University College London that focuses on 3D printing for pharmaceutical uses - and the first group to investigate Selective Laser Sintering (SLS) to make medicine. The Sintratec Kit has played a key role in that matter and is used successfully to 3D print and research personalized drugs.

Read the Full Story

Find out more about the Sintratec Kit.

FabRx: https://fabrx.co.uk/


Leave a comment

Please note, comments must be approved before they are published